Value in Prescribing biological disease-modifying antirheumatic drugs (bDMARDs) Program

Targeted Therapies Alliance

The Australian Rheumatology Association (ARA) has joined NPS MedicineWise and seven other organisations representing specialists, pharmacists, consumers and research experts to form the Targeted Therapies Alliance. The Alliance provides stewardship and direction about the safe and wise use of biological disease-modifying antirheumatic drugs (bDMARDs) and other specialised medicines. 

Inflammatory arthritis

The Targeted Therapies Alliance has developed information and resources for health professionals and consumers, including practical tools for people with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axial SpA). 

Resources for rheumatologists

Clinical Updates: An clinical update visiting service is now available for rheumatologists. These one-to-one clinical updates provide an opportunity to discuss the current best available evidence around medicines for inflammatory arthritis. Register your interest here.

For more information, visit the Rheumatology conditions for health professionals page on the NPS MedicineWise website.